Physician

Justin M Shaw, M.D.

According to 2025 Medicare claims, Justin Shaw, M.D. (NPI: 1528387438) practices ophthalmology in the Lancaster, PA market, with the plurality of this provider's patient population coming from Lancaster, PA. This provider's primary affiliated billing organization is EYE DOCTORS OF LANCASTER LTD (NPI: 1235145665; TIN: 232182421) and primary practice location at 17601-2644.

Shaw's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 475 traditional Medicare patients, billed 2,220 HCPCS/CPT codes, and received $211,744 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,292 prescription claims across 686 beneficiaries totaling $562,370 in drug costs, led by Lumigan (Bimatoprost). 2020 DME data shows 24 claims. Open Payments data shows 44 records totaling $1,061. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $81,491 and ending at $211,744. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $215,955 to $562,370. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	474	1,052	$81,491
2016	683	3,051	$258,341
2017	676	2,344	$190,052
2018	234	1,537	$178,694
2019	379	2,377	$242,105
2020	412	2,094	$214,261
2021	437	2,104	$211,065
2022	469	2,063	$208,625
2023	474	2,086	$206,840
2024	475	2,220	$211,744

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	649	2,602	$215,955
2016	701	3,352	$298,925
2017	637	4,279	$405,669
2018	410	1,854	$225,387
2019	397	2,848	$414,335
2020	501	3,984	$570,364
2021	595	4,350	$687,372
2022	664	4,726	$733,084
2023	633	4,259	$625,421
2024	686	4,292	$562,370

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	22	24	$1,808
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	163	199	$79
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	314	439	$56
92083	Exam of visual field with extended testing	242	264	$39
92136	Measurement of corneal curvature and depth of eye	85	105	$31
92133	Imaging of optic nerve	348	488	$22

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lumigan	Bimatoprost	305	14,732	$126,898
Rocklatan	Netarsudil Mesylat/Latanoprost	150	6,360	$74,745
Rhopressa	Netarsudil Mesylate	154	6,983	$66,931
Xiidra	Lifitegrast	51	2,010	$43,495
Vyzulta	Latanoprostene Bunod	113	3,828	$35,148

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	44	$1,061	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Justin M. Shaw, M.D.?

Tedicare shows public-source Medicare data for Justin M. Shaw, M.D. (NPI 1528387438), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Justin M. Shaw, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Justin M. Shaw, M.D.?

Justin M. Shaw, M.D. is linked to EYE DOCTORS OF LANCASTER LTD (billing NPI 1235145665) in the available physician profile data.

Does Justin M. Shaw, M.D. have Open Payments data?

Justin M. Shaw, M.D. has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.